跳至主要内容
临床试验/JPRN-UMIN000034778
JPRN-UMIN000034778已完成未知

Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetes - Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients

Ichinomiyanishi Hospital0 个研究点目标入组 60 人开始时间: 2018年11月5日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients admitted to or expected to require ICU admission; Patients with basal-bolus insulin therapy, corticosteroid therapy,therapy of once weekly antidiabetic agents, clinically relevant gastrointestinal disease, impaired renal function (serum creatinine >3.0 mg/dL); and patients with a history of diabetic ketoacidosis and hyperglycemic crises pregnancy, or any mental condition rendering the subject unable to give informed consent.

研究者

相似试验